Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes

Kouji Banno, Megumi Yanokura, Makiko Kawaguchi, Yoshiko Kuwabara, Jyunko Akiyoshi, Yusuke Kobayashi, Takashi Iwata, Akira Hirasawa, Takuma Fujii, Nobuyuki Susumu, Kastumi Tsukazaki, Daisuke Aoki

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

A relationship between inactivation of mitotic checkpoint genes and sensitivity of cancer cells to anticancer agents has been reported. We investigated the effect of epigenetic inactivation by aberrant hypermethylation of the mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger) on the sensitivity of cervical cancer cells to taxanes. Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens. In contrast, aberrant DNA methylation was not detected in normal cervical cells or squamous cell carcinoma cells. Aberrant methylation of CHFR was also analyzed in 6 human cervical carcinoma-derived cell lines and was observed in SKG-IIIb and HeLa cells. These cell lines showed high sensitivity to taxanes, but became taxane-resistant upon treatment with 5-azacytidine. Furthermore, suppression of CHFR expression in siRNA-transfected SKG-IIIa cells caused increased sensitivity to taxanes. In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer. To our knowledge, this study is the first to examine epigenetic inactivation by aberrant hypermethylation of CHFR in cervical cancer.

Original languageEnglish
Pages (from-to)713-720
Number of pages8
JournalInternational Journal of Oncology
Volume31
Issue number4
Publication statusPublished - 2007 Oct

Fingerprint

Taxoids
Gene Silencing
Epigenomics
Uterine Cervical Neoplasms
Methylation
M Phase Cell Cycle Checkpoints
Adenocarcinoma
Azacitidine
Cell Line
Vaginal Smears
Neoplasm Genes
DNA Methylation
HeLa Cells
Antineoplastic Agents
Patient Selection
Small Interfering RNA
Genes
Fingers
Squamous Cell Carcinoma
Carcinoma

Keywords

  • Cervical cancer
  • Chemosensitivity
  • CHFR
  • DNA hypermethyltion
  • Taxane

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. / Banno, Kouji; Yanokura, Megumi; Kawaguchi, Makiko; Kuwabara, Yoshiko; Akiyoshi, Jyunko; Kobayashi, Yusuke; Iwata, Takashi; Hirasawa, Akira; Fujii, Takuma; Susumu, Nobuyuki; Tsukazaki, Kastumi; Aoki, Daisuke.

In: International Journal of Oncology, Vol. 31, No. 4, 10.2007, p. 713-720.

Research output: Contribution to journalArticle

Banno, K, Yanokura, M, Kawaguchi, M, Kuwabara, Y, Akiyoshi, J, Kobayashi, Y, Iwata, T, Hirasawa, A, Fujii, T, Susumu, N, Tsukazaki, K & Aoki, D 2007, 'Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes', International Journal of Oncology, vol. 31, no. 4, pp. 713-720.
Banno, Kouji ; Yanokura, Megumi ; Kawaguchi, Makiko ; Kuwabara, Yoshiko ; Akiyoshi, Jyunko ; Kobayashi, Yusuke ; Iwata, Takashi ; Hirasawa, Akira ; Fujii, Takuma ; Susumu, Nobuyuki ; Tsukazaki, Kastumi ; Aoki, Daisuke. / Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. In: International Journal of Oncology. 2007 ; Vol. 31, No. 4. pp. 713-720.
@article{63738972275c4d74892b54f461105a7a,
title = "Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes",
abstract = "A relationship between inactivation of mitotic checkpoint genes and sensitivity of cancer cells to anticancer agents has been reported. We investigated the effect of epigenetic inactivation by aberrant hypermethylation of the mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger) on the sensitivity of cervical cancer cells to taxanes. Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3{\%} (2/14) of adenocarcinoma specimens. In contrast, aberrant DNA methylation was not detected in normal cervical cells or squamous cell carcinoma cells. Aberrant methylation of CHFR was also analyzed in 6 human cervical carcinoma-derived cell lines and was observed in SKG-IIIb and HeLa cells. These cell lines showed high sensitivity to taxanes, but became taxane-resistant upon treatment with 5-azacytidine. Furthermore, suppression of CHFR expression in siRNA-transfected SKG-IIIa cells caused increased sensitivity to taxanes. In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer. To our knowledge, this study is the first to examine epigenetic inactivation by aberrant hypermethylation of CHFR in cervical cancer.",
keywords = "Cervical cancer, Chemosensitivity, CHFR, DNA hypermethyltion, Taxane",
author = "Kouji Banno and Megumi Yanokura and Makiko Kawaguchi and Yoshiko Kuwabara and Jyunko Akiyoshi and Yusuke Kobayashi and Takashi Iwata and Akira Hirasawa and Takuma Fujii and Nobuyuki Susumu and Kastumi Tsukazaki and Daisuke Aoki",
year = "2007",
month = "10",
language = "English",
volume = "31",
pages = "713--720",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "4",

}

TY - JOUR

T1 - Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes

AU - Banno, Kouji

AU - Yanokura, Megumi

AU - Kawaguchi, Makiko

AU - Kuwabara, Yoshiko

AU - Akiyoshi, Jyunko

AU - Kobayashi, Yusuke

AU - Iwata, Takashi

AU - Hirasawa, Akira

AU - Fujii, Takuma

AU - Susumu, Nobuyuki

AU - Tsukazaki, Kastumi

AU - Aoki, Daisuke

PY - 2007/10

Y1 - 2007/10

N2 - A relationship between inactivation of mitotic checkpoint genes and sensitivity of cancer cells to anticancer agents has been reported. We investigated the effect of epigenetic inactivation by aberrant hypermethylation of the mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger) on the sensitivity of cervical cancer cells to taxanes. Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens. In contrast, aberrant DNA methylation was not detected in normal cervical cells or squamous cell carcinoma cells. Aberrant methylation of CHFR was also analyzed in 6 human cervical carcinoma-derived cell lines and was observed in SKG-IIIb and HeLa cells. These cell lines showed high sensitivity to taxanes, but became taxane-resistant upon treatment with 5-azacytidine. Furthermore, suppression of CHFR expression in siRNA-transfected SKG-IIIa cells caused increased sensitivity to taxanes. In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer. To our knowledge, this study is the first to examine epigenetic inactivation by aberrant hypermethylation of CHFR in cervical cancer.

AB - A relationship between inactivation of mitotic checkpoint genes and sensitivity of cancer cells to anticancer agents has been reported. We investigated the effect of epigenetic inactivation by aberrant hypermethylation of the mitotic checkpoint gene CHFR (checkpoint with forkhead and ring finger) on the sensitivity of cervical cancer cells to taxanes. Methylation-specific PCR (MSP) of cervical smears showed aberrant methylation of CHFR in 12.3% (2/14) of adenocarcinoma specimens. In contrast, aberrant DNA methylation was not detected in normal cervical cells or squamous cell carcinoma cells. Aberrant methylation of CHFR was also analyzed in 6 human cervical carcinoma-derived cell lines and was observed in SKG-IIIb and HeLa cells. These cell lines showed high sensitivity to taxanes, but became taxane-resistant upon treatment with 5-azacytidine. Furthermore, suppression of CHFR expression in siRNA-transfected SKG-IIIa cells caused increased sensitivity to taxanes. In conclusion, aberrant methylation of the CHFR gene may be useful as a molecular marker for selection of therapy for patients with cervical adenocarcinoma with a poor prognosis, and may also suggest a new therapeutic strategy of targeting CHFR in cervical cancer. To our knowledge, this study is the first to examine epigenetic inactivation by aberrant hypermethylation of CHFR in cervical cancer.

KW - Cervical cancer

KW - Chemosensitivity

KW - CHFR

KW - DNA hypermethyltion

KW - Taxane

UR - http://www.scopus.com/inward/record.url?scp=35848946152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35848946152&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 713

EP - 720

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 4

ER -